Non-alcoholic steatofibrosis (NASF) can independently predict mortality in patients with non-alcoholic fatty liver disease (NAFLD)

BACKGROUND: Hepatic fibrosis in patients with non-alcoholic fatty liver disease (NAFLD) independently predicts mortality. Given liver biopsy’s invasive nature, non-invasive method to assess hepatic steatosis and fibrosis provides NAFLD risk stratification algorithm in clinical practice. NAFLD fibros...

Descripción completa

Detalles Bibliográficos
Autores principales: Golabi, Pegah, Stepanova, Maria, Pham, Huong T, Cable, Rebecca, Rafiq, Nila, Bush, Haley, Gogoll, Trevor, Younossi, Zobair M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5873539/
https://www.ncbi.nlm.nih.gov/pubmed/29607054
http://dx.doi.org/10.1136/bmjgast-2018-000198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5873539/
https://www.ncbi.nlm.nih.gov/pubmed/29607054
http://dx.doi.org/10.1136/bmjgast-2018-000198

Ejemplares similares